• 1
    Schlund JF, Semelka RC, Kettritz U, Eisenberg LB, Lee JK. Transient increased segmental hepatic enhancement distal to portal vein obstruction on dynamic gadolinium-enhanced gradient echo MR images. J Magn Reson Imaging 1995; 5: 375377.
  • 2
    Mitchell DG. Liver I: currently available gadolinium chelates. Magn Reson Imaging Clin N Am 1996; 4: 3751.
  • 3
    Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997; 202: 268273.
  • 4
    Kanematsu M, Semelka RC, Matsuo M, et al. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases--a prospective randomized study in patients with chronic liver damage. Radiology 2002; 225: 407415.
  • 5
    Martin DR, Seibert D, Yang M, Salman K, Frick MP. Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium-enhanced MRI. J Magn Reson Imaging 2004; 20: 838842.
  • 6
    Martin DR, Semelka RC. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 2005; 26: 116131.
  • 7
    Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999; 212: 876884.
  • 8
    Martin DR, Yang M. First pass perfusion kinetics of liver: high temporal imaging for demonstration of the true arterial capillary phase of enhancement.. In: ISMRM Symposium on Molecular MR Imaging of Malignancy, 2002: A7
  • 9
    Brown ED, Semelka RC. Contrast-enhanced magnetic resonance imaging of the abdomen. Magn Reson Q 1994; 10: 97124.
  • 10
    Semelka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001; 13: 385391.
  • 11
    Materne R, Horsmans Y, Jamart J, Smith AM, Gigot JF, Van Beers BE. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000; 11: 244249.
  • 12
    Hussain HK, Londy FJ, Francis IR, et al. Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology 2003; 226: 558566.
  • 13
    Vade A, Olson MC, Vittore CP, Subbaiah P. Hepatic enhancement analysis in children using smart prep monitoring for 2 : 1 pitch helical scanning. Pediatr Radiol 1999; 29: 689693.
  • 14
    Tatli S, Lipton MJ, Davison BD, Skorstad RB, Yucel EK. From the RSNA refresher courses: MR imaging of aortic and peripheral vascular disease. Radiographics 2003; 23 Spec No: S59S78.
  • 15
    Van Beers BE, Materne R, Lacrosse M, et al. MR imaging of hypervascular liver tumors: timing optimization during the arterial phase. J Magn Reson Imaging 1999; 9: 562567.
  • 16
    Baxter S, Wang ZJ, Joe BN, et al. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging 2009; 29: 13171322.
  • 17
    Larson RE, Semelka RC. Magnetic resonance imaging of the liver. Top Magn Reson Imaging 1995; 7: 7181.
  • 18
    Sharma, P, Salman K, Burrow B, Lauenstein T, Martin D. Quantification of arterial-phase perfusion kinetics in the liver. In: Proceedings of the 15th Annual Meeting of the ISMRM, Berlin, Germany, 2007 (Abstract 2980).
  • 19
    Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008; 27: 14481454.